-+ 0.00%
-+ 0.00%
-+ 0.00%

ZURA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Zura Bio Limited

Barchart·11/10/2026 09:09:00
Listen to the news

Whether they sold following the November 9, 2026 disclosure or continue to hold their shares, Zura Bio shareholders who suffered losses after the Company announced that its Phase 2 TibuSHIELD trial failed to meet its primary endpoint may be eligible to seek recovery.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.